<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190904044695N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-10-21</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>The study of antiperspirant effect of plant extract combinations from three herbs of Salvia limbata, Equisetum Arvense and Myrtus communis spray.</public_title>
      <acronym></acronym>
      <scientific_title>Comparative study of the effectiveness of plant extract combinations from three herbs including Salvia limbata, Equisetum Arvense and Myrtus communis spray on the decrease of the amount of sweating among healthy and mature women.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/41962</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: The participants, researcher, clinical caregiver, outcome analyst, the analyzer and data monitoring safety committee were unaware of the allocation of study groups. As such, they have not been able to detect, identify or even observe the pads.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Sweating.</hc_freetext>
      <i_freetext>Intervention 1: - Intervention group: The study group consisted of females between 18 and 40 years old. Participants entered the study consciously after completing a briefing on the research objectives and how to complete the questionnaires and forms, as well as how to properly use the spray, and after filling out the consent form.This study was conducted using Triple Blind method (lack of knowledge of the participants the researcher and statistical consultant on the allocation of study groups until the end of data analysis). For each of the 24 participants in the study, on the axillary region were inserted pads with hydroalcoholic extract of Salvia limbata, Equisetum Arvense and Myrtus communis in a mixture form in 5% ethano and  the individuals were given of physical activity, and then, after 2 hours the pads were collected from the axillary region and redistributed. Weight differences were recorded before and after these two hours. This should have been done for three consecutive days. Intervention 2: The study group consisted of females between 18 and 40 years old. Participants entered the study consciously after completing a briefing on the research objectives and how to complete the questionnaires and forms, as well as how to properly use the spray, and after filling out the consent form.This study was conducted using Triple Blind method (lack of knowledge of the participants the researcher and statistical consultant on the allocation of study groups until the end of data analysis). For each of the 24 participants in the study, consisted of two treatment group on the axillary region were inserted pads with hydroalcoholic extract of Salvia limbata, Equisetum Arvense and Myrtus communis in a mixture form in 5% ethano and  the individuals were given of physical activity in the sports club of the dormitory, and then, after 2 hours the pads were collected from the axillary region and redistributed. Weight differences were recorded before and after these two hours. This should have been done for three consecutive days, and  finally the mean weight difference of the pads in three days was considered as the criterion.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Commercialization</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahdi Tavakolizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>: Zanjan Province University of Medical Sciences &amp; Health services, first of Jomhouri Ave, Azadi Blvd, Zanjan</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4515613191</zip>
        <telephone>+98 24 3347 3635</telephone>
        <email>mahdi_tavakoli@yahoo.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Faramarz Dobakhti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>: Zanjan Province University of Medical Sciences &amp; Health services, first of Jomhouri Ave, Azadi Blvd, Zanjan</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4515613191</zip>
        <telephone>+98 24 3347 3635</telephone>
        <email>fdobakhti@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>No history of hypersensitivity to natural anti-perspiration substances and compounds.
No cutaneous lesion in axillary region.
No history of metabolic disease
Not taking antihistamine drugs while studying</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Use of antiperspirant and anticholinergic drugs
People with thyroid or metabolic diseases
Sensitivity to natural and skin products</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>- Intervention group: The study group consisted of females between 18 and 40 years old. Participants entered the study consciously after completing a briefing on the research objectives and how to complete the questionnaires and forms, as well as how to properly use the spray, and after filling out the consent form.This study was conducted using Triple Blind method (lack of knowledge of the participants the researcher and statistical consultant on the allocation of study groups until the end of data analysis). For each of the 24 participants in the study, on the axillary region were inserted pads with hydroalcoholic extract of Salvia limbata, Equisetum Arvense and Myrtus communis in a mixture form in 5% ethano and  the individuals were given of physical activity, and then, after 2 hours the pads were collected from the axillary region and redistributed. Weight differences were recorded before and after these two hours. This should have been done for three consecutive days</i_keyword>
      <i_keyword>The study group consisted of females between 18 and 40 years old. Participants entered the study consciously after completing a briefing on the research objectives and how to complete the questionnaires and forms, as well as how to properly use the spray, and after filling out the consent form.This study was conducted using Triple Blind method (lack of knowledge of the participants the researcher and statistical consultant on the allocation of study groups until the end of data analysis). For each of the 24 participants in the study, consisted of two treatment group on the axillary region were inserted pads with hydroalcoholic extract of Salvia limbata, Equisetum Arvense and Myrtus communis in a mixture form in 5% ethano and  the individuals were given of physical activity in the sports club of the dormitory, and then, after 2 hours the pads were collected from the axillary region and redistributed. Weight differences were recorded before and after these two hours. This should have been done for three consecutive days, and  finally the mean weight difference of the pads in three days was considered as the criterion.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Weight difference of axillary pads. Timepoint: At the beginning of study and 2 hours after exercise. Method of measurement: Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-06-11</approval_date>
        <contact_name>Ethics committee of Zanjan University of Medical Sciences</contact_name>
        <contact_address>Zanjan Province University of Medical Sciences &amp; Health services, first of Jomhouri Ave, Azadi Blvd, Zanjan Zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
